Otolaryngology Doctors in Danvers, MA Accepting Medicare

10 Otolaryngology doctors found. Showing 1 - 10

Dr. Anna E. Petropoulos, M.D., F.R.C.S. Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Not Enrolled in Medicare Practice Location: 80 Lindall St, Danvers, MA 01923 Phone: 978-739-9500    Fax: 978-739-9502

Dr. Allen Lee Feng, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 104 Endicott St Ste 100, Danvers, MA 01923 Phone: 978-745-6601

Jordan Glicksman, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 104 Endicott St Ste 100, Danvers, MA 01923 Phone: 978-745-6601

Dr. Richard E Mugge, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 104 Endicott St, Suite 100, Danvers, MA 01923 Phone: 978-745-6601    Fax: 978-624-4040

Dr. Philip Ryan Molarte Camilon, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 104 Endicott St Ste 100, Danvers, MA 01923 Phone: 978-745-6601    Fax: 978-744-4872

Dr. James L Demetroulakos, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 104 Endicott St, Suite 100, Danvers, MA 01923 Phone: 978-745-6601    Fax: 978-624-4040

William R Nicholas, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 127 Locust St, Danvers, MA 01923 Phone: 978-774-8886

Dr. Gonzalo H Verdugo, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 104 Endicott St, Suite 100, Danvers, MA 01923 Phone: 978-745-6601

Dr. Jared Bradley Turner, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 104 Endicott St, Suite 100, Danvers, MA 01923 Phone: 978-745-6601

Dr. David Scott Chrzanowski, M.D. Otolaryngology - Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 104 Endicott St, Suite 100, Danvers, MA 01923 Phone: 978-745-6601    Fax: 978-624-4040

News Archive

Survey finds employers 'pessimistic' about health law's costs

The Wall Street Journal reports on a survey that finds companies are increasingly "pessimistic" they can avoid health care cost increases they believe will stem from the overhaul. Politico reports that insurers are showing little interest in small business exchanges.

mTOR protein plays a key role in development of diabetes

The signaling protein mTOR is a key regulator that controls cell growth. Dysfunction of mTOR increases not only the likelihood of developing cancer but also diabetes. In the current issue of the journal Cell Metabolism, Mike Hall and his team from the Biozentrum of the University of Basel describe how inhibition of mTOR signaling can impair carbohydrate metabolism and potentially lead to diabetes.

Partial breast irradiation effective alternative for treatment of low-risk breast cancer patients

Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

Surgery more effective than drug therapy in patients with tertiary hyperparathyroidism

A study led by researchers from the Nephrology group at Bellvitge Biomedical Research Institute (IDIBELL) and the University Hospital of Bellvitge (HUB), compared the results of surgery with drug therapy in patients with tertiary hyperparathyroidism, ie after a kidney transplant.

Interfering with enzyme's movement may be new approach for developing of anti-cancer drugs

Revealing all the steps required to activate an enzyme called a protein kinase may identify new ways to target cancer, according to new University of Arizona-led research.

Read more Medical News

› Verified 3 days ago